Fundz

Castle Creek Biosciences Raises $112.8 Million To Advance Novel Gene Therapies And Expand Pipeline

PRIVATEMay 25, 2022

Amount Raised

$113 Million

Round Type

Funding Round

ExtonBiotechnologyHealth Care

Description

Castle Creek Biosciences, Inc., a late-stage cell and gene therapy company using two lentiviral platforms to develop and commercialize therapies for genetic diseases, today announced an oversubscribed and upsized preferred stock financing of $112.8 million.

Quick answer

Castle Creek Biosciences, Inc raised $113 Million in a Funding Round round, dated May 25, 2022. Castle Creek Biosciences, Inc is based in Exton, Pennsylvania, United States.

How much did Castle Creek Biosciences, Inc raise?
Castle Creek Biosciences, Inc raised $113 Million in a Funding Round round on May 25, 2022.
What does Castle Creek Biosciences, Inc do?
Castle Creek Biosciences is a late-stage company developing re-dosable gene therapies.
Where is Castle Creek Biosciences, Inc based and how big is it?
Castle Creek Biosciences, Inc is based in Exton, Pennsylvania, United States. Fundz records about 31 employees.
Who are the decision-makers at Castle Creek Biosciences, Inc?
Fundz holds 1 contact at Castle Creek Biosciences, Inc, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Castle Creek Biosciences, Inc that raised within 45 days of this round, from Fundz verified event records.

  • Kernal Biologics raised $25M (Series A) on July 7, 2022.
  • Bactana raised $385K (Seed) on July 7, 2022.
  • Sanara MedTech raised $16M on July 1, 2022.
  • Aria CV raised $7.8M on July 1, 2022.
  • Faeth Therapeutics raised $47M (Funding Round) on June 30, 2022.
  • U.S. Renal Care raised $4.7M (Seed) on June 30, 2022.

Who to call at Castle Creek Biosciences, Inc, and when

A new round usually means Castle Creek Biosciences, Inc is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Castle Creek Biosciences, Inc raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Castle Creek Biosciences, Inc, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Castle Creek Biosciences, Inc. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Castle Creek Biosciences, Inc

Location

405 Eagleview Boulevard

Exton, Pennsylvania, United States

About

Castle Creek Biosciences is a late-stage company developing re-dosable gene therapies. It is preparing to launch a pivotal clinical trial of its lead candidate, D-Fi, for patients with dystrophic epidermolysis bullosa (DEB).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Castle Creek Biosciences, Inc raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMatthew G., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Castle Creek Biosciences, Inc's next move

See what Strategic adds

Castle Creek Biosciences, Inc raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.